GlassScriptPhysician profile
Lorry A Melnick
NPI 1285632752
$930.58
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2021: $20.37 · 2022: $260 · 2023: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $251.82 | 2019-2023 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $148.00 | 2022 | |
| Horizon Therapeutics Plc | $123.53 | 2023 | Krystexxa |
| Boston Scientific Corporation | $121.57 | 2019 | |
| Kci USA, INC. | $118.34 | 2023 | Activ.A.C. |
| Heron Therapeutics, INC. | $111.63 | 2022 | |
| Anika Therapeutics, INC. | $21.00 | 2023 | F&A Sports, Toe Motion, Tactoset |
| Alfasigma USA, INC. | $20.37 | 2021 | |
| Stryker Corporation | $14.32 | 2023 | Citrefix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorry Melnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.